Research ArticleClinical Investigation
The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy
Surekha Yadav, Courtney Lawhn-Heath, Alan Paciorek, Sheila Lindsay, Rebecca Mirro, Emily K. Bergsland and Thomas A. Hope
Journal of Nuclear Medicine March 2024, 65 (3) 409-415; DOI: https://doi.org/10.2967/jnumed.123.266614
Surekha Yadav
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Courtney Lawhn-Heath
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Alan Paciorek
2Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California;
Sheila Lindsay
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
3Department of Medicine, Division of Medical Oncology, University of California San Francisco, San Francisco, California;
Rebecca Mirro
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
Emily K. Bergsland
3Department of Medicine, Division of Medical Oncology, University of California San Francisco, San Francisco, California;
4Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; and
Thomas A. Hope
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California;
4Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; and
5Department of Radiology, San Francisco VA Medical Center, San Francisco, California

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy
Surekha Yadav, Courtney Lawhn-Heath, Alan Paciorek, Sheila Lindsay, Rebecca Mirro, Emily K. Bergsland, Thomas A. Hope
Journal of Nuclear Medicine Mar 2024, 65 (3) 409-415; DOI: 10.2967/jnumed.123.266614